Adam H. Schechter

Chairman, President and Chief Executive Officer
Adam H. Schechter has served as Chairman of the Board since May 13, 2020, a director of the Company since April 1, 2013, and as the President and Chief Executive Officer of the Company since November 1, 2019. Mr. Schechter previously served as special advisor to the Chief Executive Officer of Merck & Co., Inc., a pharmaceutical company, from January 2019 to July 2019. Prior to that, Mr. Schechter was an Executive Vice President of Merck, where he was a member of Merck’s executive committee and pharmaceutical and vaccines operating committee, and President of Merck’s Global Human Health Division, which includes the company’s worldwide pharmaceutical and vaccine businesses, from 2010 to 2018. Prior to becoming President, Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business of Merck from 2007 to 2010. Mr. Schechter’s extensive experience at Merck included global and U.S.-focused leadership roles spanning sales, marketing, and managed markets, as well as business and product development. He is a Board Member for and an executive board member for the National Alliance for Hispanic Health. In 2022, Mr. Schechter earned the CERT Certificate in Cybersecurity Oversight.